Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Novartis is adding to its diverse and deep immuno-oncology pipeline through a strategic alliance and licensing agreement with Surface Oncology. The agreement gives Novartis access to four pre-clinical programs that target regulatory T cell ...
read more
Celerion has announced that effective January 1, 2016, Assign Clinical Research, headquartered in Vienna, Austria, has joined Celerion, further expanding their global presence and capabilities in the conduct of complex early clinical studies.
read more
iCardiac Technologies, Inc., a scientific leader in the conduct of cardiac safety assessments, today announced it is providing industry-wide access to its pivotal dataset as part of an effort announced by the Cardiac Safety Research Consortium to ...
read more
AstraZeneca and Incyte Corporation have announced a new collaboration to evaluate the efficacy and safety of Incyte’sJanus-associated kinase (JAK) 1 inhibitor, INCB39110, in combination with AstraZeneca’s next generation epidermal growth factor ...
read more
WuXi AppTec Co. Ltd. has started construction of a state-of-the-art integrated biologics solution center at the company's headquarters in Shanghai. The company plans to invest a total of $120 million in this dedicated, 250,000-square-foot facility, ...
read more
Albany Molecular Research Inc. (AMRI) and Icagen, Inc. have signed a collaboration agreement to co-market Icagen's ion channel and transporter technology to global pharmaceutical and biotechnology clients.
read more
Recipharm has appointed Yves Buelens to the position of General Manager for its wholly owned new subsidiary Kaysersberg Pharmaceuticals SAS.
read more
Wednesday, January 06, 2016
X-Chem, Inc., a privately held biotechnology company applying its cutting-edge lead discovery capabilities to the generation of novel small molecule therapeutics, announced a multi-target collaboration with Sanofi.
read more
Wednesday, January 06, 2016
Sterigenics International, a global provider of contract sterilization, gamma technologies and medical isotopes, has announced expansion at their Forth Worth, Texas location, with the addition of a new gamma cell that will increase capacity by 30%.
read more
Wednesday, January 06, 2016
Rodin Therapeutics, a biotechnology company applying insights from epigenetics to develop novel therapeutics for neurological disorders, today announced preferred stock financing commitments totaling $17.3M from Atlas Venture and Biogen. In addition ...
read more
Wednesday, January 06, 2016
Capsugel has completed its acquisitions of Xcelience and Powdersize. Xcelience and Powdersize are now part of Capsugel's Dosage Form Solutions business unit, which partners with pharmaceutical and health and nutrition customers around the world.
read more
Wednesday, January 06, 2016
Voisin Consulting Life Sciences, a global healthcare product development consultancy, and iQone Healthcare, a specialty pharmaceutical company focused on pharmaceutical distribution, sales, marketing and contract services in Europe, have announced a ...
read more
Wednesday, January 06, 2016
Takeda Pharmaceutical has announced the acquisition of a biologics manufacturing facility located in Brooklyn Park, Minnesota, U.S. from Baxalta US Inc.
read more
PharMEDium Services, LLC is voluntarily recalling 29 lots of 4mg Norepinephrine Bitartrate (16mcg/mL) added to 0.9% Sodium Chloride in 250mL Viaflex Bag and 3 lots of 8mg Norepinephrine Bitartrate (32mcg/mL) added to 0.9% Sodium Chloride in 250mL ...
read more
Agenus Inc., an immunotherapy company developing innovative treatments for patients with cancer, announced today that it has completed the previously announced acquisition of XOMA Corporation’s antibody manufacturing pilot plant and capabilities.
read more